electroCore, Inc.

NASDAQ:ECOR

Medical - Devices

Healthcare
$7.71 -5.70%

-$0.50 today

Market cap
$71.13M
Beta
0.87
P/E (TTM)
-4.8
EPS (TTM)
-$1.72
52W Low $4.16High $10.50

Volume 0.06M

Average 0.11M

ECOR Purchases of Investments

Cash used to buy marketable securities and other investments.

electroCore, Inc.NASDAQ: ECOR

Purchases of Investments · Q1 FY2026 · quarter ended Mar 2026

Purchases of investments outflow grows to $0

Q1 FY2026 purchases of investments was $0, compared with $0 a year earlier. Trailing-twelve-month purchases of investments was $0.

Context

  • Purchases of investments amounted to 12.3% of revenue in FY2025, down 21.5 pp from a year earlier.
  • Purchases of investments increased in 1 of the last 3 fiscal years.
  • FY2025 was the highest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly purchases of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$0— QoQ
Last fiscal yearDec 2025
$3.94M+146.3% YoY
LTMMar 2026
$0+100.0% YoY
Purchases of Investments past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year+146.3%——
3-year CAGR———
5-year CAGR——
10-year CAGR——

Purchases of Investments history

USD · from the cash flow

Latest · FY2025
3.94M USD
Year-over-year change
+146.3%

Purchases of Investments vs competitors

How ECOR compares with its peers on the latest reported figures

  • ECOR's LTM Mar 2026 purchases of investments of $0 is the 2nd largest of the 6 companies compared; the peer median is $0.
  • Its year-over-year change of +100.0% is the 2nd highest of 3, against a peer median of +123.4%.
  • Purchases of investments amounts to 0.0% of revenue for ECOR, versus a peer median of 0.0%.
ECOR Competitors Peer median
Purchases of Investments for ECOR and competitors
Company Period LTM YoY 3-year CAGR% of revenue
MYOMyomo, Inc.LTM Mar 2026$4.24M +146.9%+201.7%10.3%
ECORelectroCore, Inc.LTM Mar 2026$0 +100.0%—0.0%
PYPDPolyPid Ltd.LTM Dec 2025$0 ———
MAIAMAIA Biotechnology, Inc.LTM Mar 2026$0 ———
RNXTRenovoRx, Inc.LTM Mar 2026$0 ——0.0%
HYPDHyperion DeFi, Inc.LTM Jun 2026$0 +100.0%—0.0%
Peer median (excluding ECOR) $0+123.4%+201.7%0.0%

Competitors are the stored peer set for ECOR. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(17.22M)(22.16M)(18.83M)(11.89M)(13.97M)
Depreciation & Amortization382K548K1.03M1.26M1.68M
Deferred Income Tax00000
Stock-Based Compensation3.3M2.68M1.7M1.87M1.93M
Change in Working Capital1.63M2.04M815K1.76M1.33M
Accounts Receivables(217K)37K(262K)(710K)(142K)
Inventory371K296K96K713K16K
Accounts Payables464K1.19M35K1.05M2.45M
Other Working Capital1.01M519K946K708K(999K)
Other Non-Cash Items(1.72M)244K628K51K849K
Operating Cash Flow(13.63M)(16.65M)(14.67M)(6.95M)(8.19M)
Capital Expenditures00(206K)0(66K)
Acquisitions (Net)00000
Purchases of Investments(5.08M)00(8.52M)3.94M
Sales of Investments23.3M0000
Other Investing Activities00000
Investing Cash Flow18.22M0(206K)(8.52M)3.88M
Debt Repayment00007.41M
Common Stock Issued25.68M08.14M8.3M222K
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00(657K)139K0
Financing Cash Flow25.68M07.49M8.44M7.63M
Effect of Forex Changes175K(82K)6K147K18K
Net Change in Cash30.45M(16.73M)(7.38M)(6.88M)3.34M
Free Cash Flow(13.63M)(16.65M)(14.87M)(6.95M)(8.25M)

electroCore, Inc.

NASDAQ:ECOR

Intrinsic Alpha fair value

Locked

Current Price

$7.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.